Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

Clinical trial NCT00040560 · UNKNOWN

Trial details

NCT number: NCT00040560
Sponsor: Copharos
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Neoplasms Carcinoma, Non-Small-Cell Lung Brain Neoplasms Metastases, Neoplasm

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.